Acadia Pharmaceuticals to Present Data at the 2026 American Academy of Neurology Annual Meeting Life Science Investing
Enveric Biosciences Announces Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq Rules Life Science Investing
Harmony Biosciences to Present Open-Label Extension Data From Phase 3 ARGUS Trial at the 2026 American Academy of Neurology Annual Meeting Life Science Investing
PharmaTher Supports Proposed U.S. Peptide Reclassification, Reinforcing the Strategic Value of Its Microneedle Patch Platforms for Peptide Delivery Life Science Investing
Charles River Laboratories Schedules First-Quarter 2026 Earnings Release and Conference Call Life Science Investing
Marvel Biosciences Identifies Liquid Formulations for Neurodevelopmental Disorders Life Science Investing
Tiziana Life Sciences Announces Publication of Positive Data Demonstrating Intranasal Anti-CD3 Antibody Attenuates Long COVID Neuroinflammation and Improves Cognitive Function Life Science Investing
Sona Nanotech Announces Appointment of Two Leading Oncologists To Its Scientific Advisory Board Technology Investing
Aligos Therapeutics Enters into Exclusive License Deal with Xiamen Amoytop Biotech Co., Ltd. to Develop and Commercialize Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection Life Science Investing
Covalon Technologies Reports Significant Milestones Spanning Vascular Access, Infection Prevention, and Wound Care Life Science Investing
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board for Phase 3 Study in Metastatic Breast Cancer
